Naltrexone Kit
Product Images NDC 69238-2794

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Naltrexone (NDC 69238-2794). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Naltrexone For Extended Release Injectable Suspens 1)

Illustration of a Naltrexone extended-release injectable suspension kit by Amneal Pharmaceuticals NY LLC, showing single-dose carton components: vial with microspheres, diluent, prepackaged syringe, plus preparation and administration needles in 1.5-inch and 2-inch sizes with needle protection devices. Directions and medication guide included.*

FDA Label Image

Figure J (Naltrexone For Extended Release Injectable Suspens 10)

Black-and-white line drawing showing a hand holding a syringe with a needle attached. The illustration appears to demonstrate the correct way to hold the syringe for injection related to the Naltrexone kit by Amneal Pharmaceuticals NY LLC.*

FDA Label Image

Structural Formula (Naltrexone For Extended Release Injectable Suspens 11)

Chemical structure of naltrexone showing its molecular framework including hydroxyl groups and a cyclopropylmethyl substitution on the nitrogen atom.*

FDA Label Image

Figure 1 (Naltrexone For Extended Release Injectable Suspens 12)

A line graph comparing the percent of patients over percent of opioid-free weeks between Naltrexone for extended-release injectable suspension and placebo groups. The graph shows patient retention trends, with the Naltrexone group represented by a solid black line and the placebo group by a lighter dashed line, across various thresholds of opioid-free weeks.*

FDA Label Image

Carton (Naltrexone For Extended Release Injectable Suspens 13)

Naltrexone for Extended-Release Injectable Suspension 380 mg/vial kit packaging label by Amneal Pharmaceuticals NY LLC. The label includes dosing instructions, storage conditions, and a barcode with NDC 69238-2794. The package is for single-dose use and specifies intramuscular injection only.*

FDA Label Image

Figure B (Naltrexone For Extended Release Injectable Suspens 2)

An instructional illustration showing hands preparing medication using a vial and syringe. One hand removes a cap from a vial, another hand holds the vial inverted, and a syringe is inserted into the vial to draw liquid medication. The image is likely part of assembly or administration instructions for the Naltrexone kit by Amneal Pharmaceuticals NY LLC.*

FDA Label Image

Figure C (Naltrexone For Extended Release Injectable Suspens 3)

An instructional illustration showing hands preparing a syringe by inserting it into a vial, likely part of a medication kit for Naltrexone. The image demonstrates the process of drawing medication from the vial into the syringe.*

FDA Label Image

Figure D (Naltrexone For Extended Release Injectable Suspens 4)

An instructional illustration showing a hand gripping a vial with a flip-off cap. The image demonstrates the motion of removing the cap by lifting it upwards with a pivoting action.*

FDA Label Image

Figure E (Naltrexone For Extended Release Injectable Suspens 5)

An instructional line drawing showing hands drawing liquid from a vial into a syringe. A boxed close-up highlights the vial's rubber stopper being punctured by the syringe needle, demonstrating preparation steps for Naltrexone kit use.*

FDA Label Image

Figure F (Naltrexone For Extended Release Injectable Suspens 6)

An instructional diagram showing hands preparing a syringe with a vial or ampule, demonstrating a step to insert or withdraw liquid. The image includes motion arrows indicating the direction of hand movements, likely part of usage instructions included in the Naltrexone kit by Amneal Pharmaceuticals.*

FDA Label Image

Figure G (Naltrexone For Extended Release Injectable Suspens 7)

An instructional illustration depicting two steps of preparing a syringe. The left side shows one hand attaching or removing a cap from a syringe needle held by the other hand. The right side shows one hand holding a syringe with the needle inserted and the other hand drawing liquid into the syringe barrel.*

FDA Label Image

Figure H (Naltrexone For Extended Release Injectable Suspens 8)

An instructional diagram showing a hand holding a syringe poised above a bent arm, illustrating the step of injecting, with an arrow indicating the downward motion of the needle into the arm. The arm features a tourniquet and markings for injection sites.*

FDA Label Image

Figure I (Naltrexone For Extended Release Injectable Suspens 9)

An instructional illustration showing a hand holding a syringe with a needle cover being removed or flipped open. The image likely demonstrates the first step in preparing an injectable medication from a kit, specifically for Naltrexone by Amneal Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.